STOCK TITAN

Insulet (PODD) officer reports PSU share award and tax withholding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Insulet Corporation executive Lauren Budden reported equity compensation activity involving company common stock. On February 12, 2026, Budden acquired 1,808 shares of Insulet common stock at $0 per share through the settlement of performance share units that vested based on performance criteria.

Upon completion of these awards, 622 shares were withheld at a price of $240.82 per share to cover related tax obligations, a non‑market, tax-withholding disposition. After these transactions, Budden directly beneficially owned 8,188 shares of Insulet common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Budden Lauren

(Last) (First) (Middle)
C/O INSULET CORPORATION
100 NAGOG PARK

(Street)
ACTON MA 01720

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Group VP, CAO and Controller
3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/12/2026 A 1,808(1) A $0 8,810(2) D
Common Stock 02/12/2026 F 622(3) D $240.82 8,188 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares issued upon the satisfaction of performance criteria related to Performance Share Units ("PSUs"). The PSUs were settled in shares of common stock on a one-for-one basis.
2. Includes 86 shares acquired under the Insulet Corporation Employee Stock Purchase Plan since the date of the Reporting Person's last Form 4 filing.
3. This transaction represents the withholding of shares upon the vesting of PSUs to cover the associated tax obligations.
/s/ Patricia K. Dolan, attorney-in-fact 02/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did PODD executive Lauren Budden report on February 12, 2026?

Lauren Budden reported receiving 1,808 shares of Insulet common stock as an equity award and having 622 shares withheld to cover taxes. Both transactions occurred on February 12, 2026 and involved directly held Insulet shares.

Was the PODD insider transaction an open-market buy or sell of shares?

The transactions were not open-market trades. Shares were acquired through the vesting of performance share units, and a portion was disposed of only as tax withholding. No open-market buying or selling activity was disclosed in this Form 4.

How many Insulet (PODD) shares does Lauren Budden own after the reported Form 4 transactions?

After the equity award and tax withholding, Lauren Budden directly beneficially owns 8,188 shares of Insulet common stock. This reflects her holdings following the February 12, 2026 grant and the related share withholding for tax obligations.

What is the nature of the 1,808 Insulet (PODD) shares reported as acquired by Lauren Budden?

The 1,808 shares represent common stock issued when performance criteria for previously granted performance share units were satisfied. These units settled into Insulet common shares on a one-for-one basis as part of Budden’s compensation package.

Why were 622 Insulet (PODD) shares disposed of in Lauren Budden’s Form 4?

The 622 shares were withheld to satisfy tax obligations triggered by the vesting and settlement of performance share units. This tax-withholding disposition is a standard administrative transaction rather than a discretionary open-market share sale.

What role does Lauren Budden hold at Insulet (PODD) according to this Form 4?

Lauren Budden is identified as an officer of Insulet, serving as Group VP, Chief Accounting Officer and Controller. The Form 4 reports changes in her directly held Insulet common stock related to equity compensation and tax withholding.
Insulet Corp

NASDAQ:PODD

PODD Rankings

PODD Latest News

PODD Latest SEC Filings

PODD Stock Data

17.08B
70.13M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ACTON